Trials / Unknown
UnknownNCT03083860
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Brainmarc Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of migraine management mobile app combined with electrophysiological measurements for identification of migraine attack risk and beneficial preventive actions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BEI | BrainMARC Ltd. has demonstrated in recent years the ability to extract effective attention markers from averaged ERP waves sampled with a single EEG channel (two electrodes). In addition, BrainMARC has developed a template matching method to extract the attention-related markers at the single-trial level. An index (termed Brain Engagement Index - BEI) can then be generated from a 1-minute, single-channel sample. |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2018-04-01
- Completion
- 2018-12-01
- First posted
- 2017-03-20
- Last updated
- 2017-06-16
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03083860. Inclusion in this directory is not an endorsement.